Join us for this live webinar to learn about Molecular Classification-based identification of diagnostic and treatment targets in glioma.
Dr. Xiaolong Fan, professor at Beijing Normal University in China will provide a high-level overview of his experience in dealing with the challenges of this project. His team has been pursuing this project for about 15 years and he will describe more about his future research plans.
Key learnings of the webinar
- Despite detailed characterization of genomic alterations, subtype-specific vulnerabilities and treatment options in gliomas are hitherto not identified
- Based on the known developmental pathways converged between brain development and glioma, we developed an EM/PM classification scheme independent of morphological subtypes and grades
- While genetic makeup may change during glioma progression and/or across different tumor areas, developmentally anchored EM/PM subtypes are highly stable and contain subtype-specific vulnerabilities.
Date: Thursday 18th November 2021
Time: 11:00 – 12:00 CET
|10:50||Online platform opens for registering participants|
David Munis Zepernick, Head of Business Development and Public Affairs, Medicon Valley Alliance
|11:05||Molecular Classification-based identification of diagnostic and treatment targets in glioma|
Dr. Xiaolong Fan, Professor at Beijing Normal University
Moderated by Nicholas Gouw Marketing Specialist at GenScript Europe
|11:00||End of webinar|
|Organized by||In collaboration with|